Literature DB >> 25506789

In vivo tracking and fate of intra-articularly injected superparamagnetic iron oxide particle-labeled multipotent stromal cells in an ovine model of osteoarthritis.

Uta Delling1, Walter Brehm, Marco Metzger, Eberhard Ludewig, Karsten Winter, Henriette Jülke.   

Abstract

In this study, superparamagnetic iron oxide (SPIO) particle-labeled mesenchymal stromal cells (MSCs) were injected intra-articularly into osteoarthritic knee joints. Their fate and distribution were evaluated using magnetic resonance imaging (MRI) and macroscopic and histologic postmortem examination. Osteoarthritis was induced in 12 sheep by bilateral meniscectomy. After 6 weeks, one knee joint received 10 × 10(6) SPIO-labeled MSCs (Molday Ion Rhodamine B). Contralateral knees received a control injection of a) PBS, b) SPIO in PBS, c) 10 × 10(6) nonvital SPIO-labeled MSCs in PBS, or d) no injection. MR images were acquired immediately after injection and 1, 4, 8, and 12 weeks thereafter using a 0.5-T unit and a T2* sequence. Signal intensity of synovial fluid and synovial lining was assessed semiquantitatively using a scoring system. Viable SPIO-labeled MSCs produced a strong hypointense signal in the synovial fluid immediately after injection, but normal signal intensity of the synovial fluid was observed 1 week later. Synovial lining maintained its hypointensity throughout the study period. Nonvital SPIO-labeled MSCs induced hypointense signals of the synovial fluid; synovial lining appeared weak and inconsistently hypointense in the following weeks. Pure SPIO produced a strong hyperintense signal in the synovial fluid at the time of injection only. Histologically, in all knee joints receiving viable SPIO-labeled MSCs, SPIO particles were detected (Prussian blue) within the synovial lining, dorsal fat pad, and neomeniscus tissue, but not in osteochondral samples. Few SPIO particles were detected in joints injected with nonvital SPIO-labeled MSCs. Immunohistologically, no increased cell death (TUNEL) was observed in the area of detected SPIO particles, but we did observe potential chondrogenic cell differentiation (Safranin O or S100β). We conclude that viable SPIO-labeled MSCs remain detectable within the joint for 12 weeks and attach themselves to some but not all diseased joint structures.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25506789     DOI: 10.3727/096368914X685654

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  11 in total

Review 1.  Meniscectomy-induced osteoarthritis in the sheep model for the investigation of therapeutic strategies: a systematic review.

Authors:  Francesca Veronesi; Filippo Vandenbulcke; Kevin Ashmore; Berardo Di Matteo; Nicolò Nicoli Aldini; Lucia Martini; Milena Fini; Elizaveta Kon
Journal:  Int Orthop       Date:  2020-02-05       Impact factor: 3.075

Review 2.  Mesenchymal Stem/Progenitor Cells Derived from Articular Cartilage, Synovial Membrane and Synovial Fluid for Cartilage Regeneration: Current Status and Future Perspectives.

Authors:  Yi-Zhou Huang; Hui-Qi Xie; Antonietta Silini; Ornella Parolini; Yi Zhang; Li Deng; Yong-Can Huang
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

3.  Pericellular collagen I coating for enhanced homing and chondrogenic differentiation of mesenchymal stem cells in direct intra-articular injection.

Authors:  Hansong Xia; Chi Liang; Pan Luo; Junjie Huang; Jinshen He; Zili Wang; Xu Cao; Cheng Peng; Song Wu
Journal:  Stem Cell Res Ther       Date:  2018-06-27       Impact factor: 6.832

4.  Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model.

Authors:  A B Ahrberg; C Horstmeier; D Berner; W Brehm; C Gittel; A Hillmann; C Josten; G Rossi; S Schubert; K Winter; J Burk
Journal:  BMC Musculoskelet Disord       Date:  2018-07-18       Impact factor: 2.362

5.  Non-Invasive Cell Tracking with Brighter and Red-Transferred Luciferase for Potential Application in Stem Cell Therapy.

Authors:  Lei Dou; Ethan L Matz; Xin Gu; Fangpeng Shu; Jennifer Paxton; Jinlin Song; James Yoo; Anthony Atala; John Jackson; Yuanyuan Zhang
Journal:  Cell Transplant       Date:  2019-11-05       Impact factor: 4.064

Review 6.  Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do.

Authors:  Iris Ribitsch; Pedro M Baptista; Anna Lange-Consiglio; Luca Melotti; Marco Patruno; Florien Jenner; Eva Schnabl-Feichter; Luke C Dutton; David J Connolly; Frank G van Steenbeek; Jayesh Dudhia; Louis C Penning
Journal:  Front Bioeng Biotechnol       Date:  2020-08-13

Review 7.  Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications.

Authors:  Wei-Zhan Zhuang; Yi-Heng Lin; Long-Jyun Su; Meng-Shiue Wu; Han-Yin Jeng; Huan-Cheng Chang; Yen-Hua Huang; Thai-Yen Ling
Journal:  J Biomed Sci       Date:  2021-04-14       Impact factor: 8.410

8.  Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.

Authors:  Aimée C Colbath; Steven W Dow; Leone S Hopkins; Jennifer N Phillips; C Wayne McIlwraith; Laurie R Goodrich
Journal:  Equine Vet J       Date:  2020-02-14       Impact factor: 2.888

9.  Longitudinal Cell Tracking and Simultaneous Monitoring of Tissue Regeneration after Cell Treatment of Natural Tendon Disease by Low-Field Magnetic Resonance Imaging.

Authors:  Dagmar Berner; Walter Brehm; Kerstin Gerlach; Claudia Gittel; Julia Offhaus; Felicitas Paebst; Doreen Scharner; Janina Burk
Journal:  Stem Cells Int       Date:  2016-01-10       Impact factor: 5.443

Review 10.  Animal mesenchymal stem cell research in cartilage regenerative medicine - a review.

Authors:  Mudasir Bashir Gugjoo; Mujeeb-Ur Rehman Fazili; Mohmmad Abrar Gayas; Raja Aijaz Ahmad; Kuldeep Dhama
Journal:  Vet Q       Date:  2019-12       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.